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ABSTRACT
INTRODUCTION Enhanced recovery programmes (ERPs) reduce patient morbidity and mortality, and provide significant cost sav-
ings by reducing length of stay. Currently, no uniform ERP guidelines exist for lower limb arthroplasty in the UK. The aim of this
study was to identify variations in ERPs and determine adherence to local policy.
METHODS Hospitals offering elective total knee arthroplasty (TKA) and total hip arthroplasty (THA) (23 and 22 centres respec-
tively) contributed details of their ERPs, and performed an audit (15 patients per centre) to assess compliance.
RESULTS Contrasting content and detail of ERPs was noted across centres. Adherence to ERPs varied significantly (40–100% for
TKA, 17–94% for THA). Analysis identified perioperative use of dexamethasone, tranexamic acid and early mobilisation for TKA,
and procedures performed in teaching hospitals for THA as being associated with a reduced length of stay.
CONCLUSIONS This study highlights variation in practice and poor compliance with local ERPs. Given the proven benefits of
ERPs, evidence-based guidelines in the context of local skillsets should be established to optimise the patient care pathway.
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Total knee and hip arthroplasty (TKA and THA respectively)
are widely recognised as being among the most clinically
effective and cost-effective procedures for end-stage, symp-
tomatic osteoarthritis. Over 145,000 National Health Service
(NHS) knee and hip arthroplasty procedures are performed
annually in the UK.1 There has been significant interest in
factors that the surgeon and healthcare provider can opti-
mise to improve patient outcomes and reduce length of stay
(LOS).2,3
Enhanced recovery programmes (ERPs) were first pro-
posed in 1997 by Kehlet as a means to reduce the surgical
stress response.4 By using multimodal techniques, ERPs can
reduce patient morbidity and mortality; they are therefore
associated with significant cost savings through reduced
LOS and healthcare associated costs.5–10 Furthermore, there
is emerging evidence that in addition to the short-term ben-
efits, ERPs may be associated with reduced mortality in the
longer term as well as superior long-term functional out-
comes.4,11 Two decades on, the complexity of ERPs has
increased, with interventions implemented pre, intra and
postoperatively.2,3 While there is strong evidence behind
certain components of ERPs, the evidence behind others is
lacking and as such, what constitutes the gold standard ERP
has yet to be defined.2,3
This study had two aims. The first was to assess the var-
iation in current practice in the NHS with regard to local
ERPs. The second was to determine compliance with these
protocols within individual trusts.
Methods
A national, multicentre audit of ERPs in knee and hip arthro-
plasty was conducted between October 2014 and April 2015
at 37 NHS hospitals. The study was conceived and led by the
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Nuffield Department of Orthopaedics, Rheumatology and
Musculoskeletal Sciences, and coordinated through the Brit-
ish Orthopaedic Network Environment (BONE), an online
orthopaedic research group (organised by the British Ortho-
paedic Trainees Association), where collaborators were
recruited and coordinated.12 Ethical approval was not
required as assessed using the Health Research Authority
online decision tool (http://www.hra-decisiontools.org.uk/
research/). All collaborators registered the study with their
respective base hospitals.
Each participating centre provided details of their local
ERP policy as well as data on compliance with their policy
for a consecutive series of 15 patients. Patients were
included in the study if they were aged over 18 years,
undergoing elective primary total knee or hip arthroplasty,
suitable for an ERP and had single joint surgery.
Data collection
A proforma containing the core elements of an ERP2 was
designed and circulated to all participating centres. Collabo-
rators entered the details of their centre’s ERP and were free
to expand the proforma if their ERP contained additional
components. Patients’ age and sex were recorded on the
proforma in addition to whether the described element of
that centre’s ERP had been completed. The proformas can
be accessed via: http://bone.ac.uk/audit/project/9 (login
required).
Statistical analysis
The mean LOS of patients attending for joint replacement in
the UK is 5 days, with a reduction by 1 day being considered
clinically significant.13 Assuming a standard deviation of 1.5
days,14 a sample size of 74 patients (37 per arm) is required
to detect a clinically relevant difference with 90% power and
1% two-sided significance.
All analysis was performed using SPSS® version 20.0
(IBM, New York, US). Mann–Whitney U tests were used to
determine statistical significance when establishing
whether any given element of an ERP caused a significant
reduction in patient LOS, with a p-value of <0.05 considered
statistically significant.
Results
During the study period, 23 centres provided information
regarding their TKA ERPs and 22 centres did so for THA
ERPs. Of these, 18 and 16 contributed compliance data for
their hospital for TKA and THA respectively. The recruit-
ment process is summarised in Figure 1. Participating
centres varied in terms of size of hospital (number of beds),
type of hospital (district general or teaching hospital) and
geography across the UK.
Compliance with local policy was assessed in 510 patients
(270 TKA and 240 THA procedures). The mean age for the
TKA patients was 70.4 years (range: 48–90 years), with just
Initial Recruitment Cohort:
37 centres
14 centres primarily excluded:
6 inadequate ERP data
4 no ERP currently in place (5 for THA ERP)
5 did not complete within deadline
Centres providing TKA ERP data:
23 centres
Centres providing THA ERP data:
22 centres
Centres also providing usable
compliance data for THA:
16 centres
Centres also providing usable
compliance data for TKA:
18 centres
Figure 1 Summary of the recruitment process
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over half (55%) being female. For the THA cohort, the mean
age was 70.0 years (range: 64–77 years) and almost two-
thirds (61%) were female. Table 1 shows the proportion of
centres that recommended different ERP elements as well as
the proportion of centres that followed these suggestions.
Patient education
For TKA ERPs, there was wide variation with regard to deliv-
ery of patient education, ranging from simple written advice
(booklets) to ‘joint schools’ (run by multidisciplinary teams
consisting of physiotherapists, occupational therapists, pain
specialist nurses and anaesthetists), with joint schools being
offered in two centres. Patient education was delivered by a
surgeon in 38% of occasions.
Where preoperative education was provided for THA
ERPs, this was delivered in person in all centres and sup-
ported by written material in two centres.
Body habitus
Patient body habitus was assessed in 17 centres using pre-
dominantly the body mass index (BMI). In one centre, the
patient’s weight alone was used. Despite the inconsistency
in how body habitus is gauged, it appears to be of impor-
tance to clinicians as it is assessed in over 80% of centres for
both TKA and THA patients. Currently, there is no consensus
regarding the appropriate point at which BMI should be
acted on. Often this is a nominal threshold (varying from
BMI >35kg/m2 to >50kg/m2) and once this threshold has
been crossed, the appropriate management is considered to
be either referral to bariatric services or referral back to the
patient’s primary care physician.
Physiology
Minimum acceptable preoperative haemoglobin values
were defined in 30% of ERPs. The thresholds varied signifi-
cantly between centres, from >10g/dl to >13g/dl. In addition,
two centres provided guidance regarding preoperative blood
transfusions if haemoglobin was low.
Interventions after admission prior to surgery
Patients were offered carbohydrate loading before surgery
in 30% of ERPs for TKA and 56% of ERPs for THA. This var-
ied in terms of volume (from 400ml to 800ml) and timing
(from the night before surgery to 2–3 hours before com-
mencing surgery). Preoperative fasting otherwise was either
stated to be for a minimum of six hours, or specific instruc-
tions were given to patients who were attending for morning
or afternoon lists.
In all centres, fasting was advised for six hours prior to
the start time of the operating list, with clear fluid permitted
Table 1 A summary of the most frequently recommended ERP components (present in at least half of audited centres) and the
respective adherence to these elements
ERP element Knee ERPs Hip ERPs
Proportion of centres
that recommend
Proportion of centres
that adhere where
offered
Proportion of centres
that recommend
Proportion of centres
that adhere where
offered
Patient education 76% 90% 90% 81%
Assessment of body habitus 81% 87% 82% 88%
Same day admission to surgery 71% 98% 90% 93%
Preoperative gabapentinoid 62% 46% 73% 45%
Wound local anaesthetic 50% 78% 73% 89%
Tranexamic acid 67% 73% 77% 82%
Early mobilisation and physiotherapy 76% 47% 82% 51%
Postoperative paracetamol 81% 85% 82% 100%
Postoperative NSAIDs 57% 76% 82% 54%
Postoperative opioids 67% 61% 82% 87%
Postoperative gabapentinoid 52% 17% 77% 72%
Postoperative antiemetic 67% 52% 77% 85%
Postoperative laxatives 52% 48% 64% 79%
Specific postoperative ward 67% 88% 82% 99%
ERP = Enhanced recovery programme; NSAIDs = non-steroidal anti-inflammatory drugs
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until two hours before the start time. In 87% of centres, the
time of fasting varied depending on whether the operation
was on a morning or afternoon list.
Venous thromboembolism prophylaxis
Eleven centres specified chemical prophylaxis with low
molecular weight heparin (LMWH) such as enoxaparin or
dalteparin, depending on renal function. Use of oral anticoa-
gulants (factor Xa inhibitors) such as apixaban and rivaroxa-
ban was also mentioned in 10% of TKA ERPs.
For THA, LMWH was recommended in 45% of ERPs and
factor Xa inhibitors in 23%. Venous thromboembolism pro-
phylaxis was not mentioned in 32% of ERPs.
Analgesia
Pre-emptive analgesia included paracetamol, opioids (con-
trolled release oxycodone, fentanyl patch) and gabapenti-
noids. Other medications prescribed included antiemetics,
proton pump inhibitors (omeprazole and lansoprazole) and
the histamine antagonist ranitidine. There was no consen-
sus on the dose, timing or frequency of analgesics.
Anaesthetic considerations
Of the centres that provided anaesthetic advice for TKA, the
majority (9 centres) recommended spinal anaesthetic, with
some specifying anaesthetic agents (isobaric bupivacaine
commonly recommended). Alternatives included combina-
tions of general and spinal anaesthetics, and use of short act-
ing anaesthetics, with two centres suggesting intravenous
propofol.
For THA, anaesthetic type was specified in 14 ERPs. Spinal
or epidural anaesthesia (with or without sedation) was rec-
ommended in 12 ERPs and general anaesthesia in 2 ERPs.
Intraoperative analgesics
A combination of intraoperative drugs were prescribed for
ERPs. Most commonly these were paracetamol, dexametha-
sone, antiemetics (particularly ondansetron) and opioids.
Timing of administration and dosages varied or was not
specified.
Local anaesthetics were administered periarticularly dur-
ing surgery. Ten centres recommended local anaesthetics,
with six suggesting ropivacaine of varying concentrations
(either 0.2% or 0.25% at volumes between 80ml and 200ml),
two suggesting 30ml of 0.5% levobupivacaine in 100ml of
0.9% saline with 1:1,000 adrenaline and two recommending
unspecified regional anaesthesia.
Tranexamic acid
Tranexamic acid was advised in 13 centres for TKA (at doses
varying from 15mg/kg to 1g/kg in the majority of centres)
and in 17 centres for THA (at doses from 1g/kg to 2g/kg).
Early mobilisation
Sixteen TKA ERPs and twelve THA ERPs mentioned early
mobilisation. This was inconsistent in that certain centres
stated mobilisation should occur within two hours or four
hours of the operation (with a further caveat of mobilisation
only being allowed if the blood pressure was within 10% of
the preoperative value) whereas others specified that
patients should be exercising in bed on ‘postoperative day 0’.
Postoperative analgesia
Three centres with TKA ERPs recommended postoperative
analgesia by intra-articular catheter. Ropivacaine was the
analgesic of choice; however, different regimens of adminis-
tration were apparent, with either boluses or regular vol-
umes suggested. Paracetamol and non-steroidal anti-
inflammatory drugs were also recommended postopera-
tively, with ibuprofen and diclofenac mentioned specifically.
Finally, opioids of varying formulation were suggested in 14
centres and gabapentinoids in 11.
Other postoperative medications
Antiemetics were prescribed in 14 centres for TKA and 22
centres for THA. Combinations of cyclizine and ondansetron
were used most often. Ephedrine (indicated for unsteadiness
when attempting to mobilise postoperatively or postural
hypotension) and lansoprazole were advised in three ERPs.
Varying laxative regimes were suggested postoperatively
such as osmotic, stimulant and polyethylene glycol-based
laxatives and stool softeners, with combinations of these lax-
ative types prescribed.
Patient discharge
Specific postoperative wards were recommended in 14 TKA
ERPs while regular physiotherapy and occupational therapy
input was suggested in 11 centres. Twelve ERPs had target
discharge times (range: 2–5 days, mean: 3.2 days). In ten
centres, patients were provided with information on precau-
tions to take to avoid damaging the knee postoperatively.
Seven of these centres also provided raised seats. Advice
was given about sleeping positions in four centres.
For THA, 20 ERPs had target discharge times. These
ranged from 2 to 5 days (mean: 3.5 days).
Length of stay
For 2014–2015 the national mean for LOS for TKA in the
NHS was 4.9 days15 whereas our audited centres (all with an
ERP in place) had a mean LOS of 3.9 days (range: 2–20
days). Intraoperative administration of dexamethasone (-1.4
days, p<0.001), tranexamic acid (-2.6 days, p<0.001), and
early mobilisation and physiotherapy input (defined as
occurring <24 hours postoperatively) (-2.4 days, p=0.019)
were associated with a reduced LOS. Patient education (+1.1
days, p=0.21, p=0.21) and prescribing gabapentinoids during
patient admission (-1.4 days, p=0.14) had no significant
impact on LOS.
The mean LOS for patients undergoing THA in centres
with an ERP in place was 4.2 days (range: 2–23 days). The
national mean in 2014–2015 was 5.4 days.15 Patients under-
going primary THA at a teaching hospital rather than a dis-
trict general hospital had a shorter LOS (-1.2 days, p=0.002).
Preoperative education (+0.9 days, p=0.09) and use of gaba-
pentinoids (-0.3 days, p=0.79) had no significant impact on
LOS.
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Discussion
This is the first study of its kind to highlight the variation in
both ERP elements and compliance for lower limb arthro-
plasty across the NHS. The study also confirmed widespread
uptake of some ERP components with limited evidence
regarding their effectiveness at the expense of other inter-
ventions with a much stronger evidence base.2,3
Our study found that patients undergoing TKA who
received dexamethasone and tranexamic acid and who
attempted early mobilisation had a significantly reduced
LOS. For THA, the type of hospital in which patients under-
went their procedure had the greatest impact on LOS.
Patient education and use of gabapentinoids had no influ-
ence on LOS in either of the cohorts.
Tranexamic acid has been found in a number of studies
to reduce postoperative bleeding and the incidence of
blood transfusion while not increasing the propensity for
patients to develop thrombosis in the postoperative
period.16–18 This has also been shown to translate to a
reduced LOS for patients.19
Similarly, in studies where patients have received dexa-
methasone, shorter stays in hospital have been noted.20
This reflects the data obtained in our study, where the sig-
nificant difference can be explained in part by the antie-
metic and opioid-sparing effects of dexamethasone.21
Furthermore, there is evidence that postoperative mobi-
lisation of patients on the same day as their TKA procedure
reduces LOS by an average of 69 hours compared with
patients mobilised on the first postoperative day.22 This
highlights the importance of increasing adherence to early
mobilisation after surgery.
Pre-emptive analgesia is another preoperative mecha-
nism that has been demonstrated to reduce LOS as it helps
to manage pain, thereby increasing patient mobility while
reducing analgesic requirements. Hebl et al compared
patients managed with multimodal analgesia with historical
controls undergoing identical surgical procedures using tra-
ditional anaesthetic techniques.23 Multimodal analgesia dis-
couraged use of intravenous opioids and emphasised
regional nerve blocks. The LOS of patients receiving multi-
modal analgesia was 1.2 days less, with improved range of
motion by 5° of flexion as well as a lower rate of adverse
reactions such as urinary retention and ileus formation. Our
study suggests that most centres are not yet fully utilising
the multimodal analgesic strategies that have been shown to
improve perioperative outcomes and reduce adverse events.
The route of administration and type of analgesics used
intraoperatively have also been noted to have a significant
impact on perioperative outcomes, with peripheral nerve
block analgesic regimes leading to fewer adverse events
than traditional oral analgesics.23 Another widely used and
increasingly popular technique is local infiltration anaesthe-
sia, whereby a mixture of anaesthetic agents (often ropiva-
caine, ketorolac and adrenaline)24 are administered
intraoperatively into the surgical site.25 This was used in the
majority of audited centres. This method has been found to
reduce time to mobilisation after surgery by 4–6 hours and
has facilitated discharging hip arthroplasty patients after
one night’s hospital stay.24
Gabapentinoids have been associated with antiemetic
effects as well as reducing postoperative nausea and vomit-
ing, and urinary retention however the weight of evidence
suggests that this does not translate to decreased LOS.26,27
Lunn et al have stated that gabapentin should not be recom-
mended as a standard of care in TKA as it has limited anal-
gesic effects in opioid-naive patients,28 with a similar
conclusion drawn by Paul et al for THA patients.29
Patient education sessions, conducted by phone or in per-
son, have been employed to manage patient expectations as
well as encourage preoperative exercise, nutritional
changes and weight management.30,31 Patient education
was heralded as the reason for reducing LOS by one day on
average for patients undergoing arthroplasty of the knee or
hip in a study by Yoon et al30 but a Cochrane review from
2014 suggests that patient education may particularly benefit
certain patients, such as those with ‘depression, anxiety or
unrealistic expectations’.32
Having considered traditional forms of pharmacological
analgesia, it is important to discuss Kehlet’s call for use of
multimodal techniques to improve patient recovery, for
instance with methods such as cryotherapy. Since a Cochrane
review published in 2012 stated that the potential benefits of
cryotherapy may be too small to justify use while also high-
lighting the need for further studies,33 a number of rando-
mised trials have been published.34–37 Leegwater et al
demonstrated that patients receiving cryotherapy during
recovery from THA had shorter hospital stays, decreased
analgesic use and improved pain scores at six weeks after
surgery compared with controls.34 Despite this, others have
shown that there is no further benefit in providing cryother-
apy by means of expensive kits compared with treatment
using crushed ice packs.36,37 Examining the evidence, simple
cryotherapy is a relatively inexpensive method that is worth
considering for TKA/THS ERPs at the very least.
This study does have certain limitations. Although the
total sample size of 510 was adequate, given the high varia-
tion in clinical practice with regard to ERP components, it
did not permit regression analysis. Moreover, LOS was
employed as a surrogate measure of an ‘enhanced recovery’
and no account was made for readmissions or long-term
morbidity or mortality. Further studies should therefore use
larger patient cohorts to permit logistic regression and col-
lect holistic outcome measures that are more representative
of improved patient care.
This study has highlighted the great variation between
centres in the NHS as well as discrepancies in practice
within centres themselves. There are indications that
patients are receiving varying degrees of preoperative opti-
misation, analgesia, antiemetics and postoperative care, and
that this is causing longer hospital stays with the ensuing
financial burden. With over 145,000 knee and hip proce-
dures performed annually in NHS hospitals1 (and an addi-
tional night in hospital costing approximately £300 on
average),38 if the NHS were to routinely implement some of
the interventions suggested in this paper, it could save over
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£43 million per year just for these two procedures. Evi-
dence-based practice should be considered by all elective
orthopaedic hospitals in the context of enhanced recovery
and guidelines should be put in place to provide optimum
patient care.
Conclusions
There is overwhelming evidence to show the benefits of
ERPs, and in particular, use of multimodal analgesia, tra-
nexamic acid and early mobilisation. There is a large varia-
tion in perioperative practice in the NHS for both TKA and
THA, with only a minority of hospitals currently implement-
ing a complete ERP. Adherence to ERPs varies significantly
within hospitals between patients but also on a national
level. Clinicians and institutions must recognise the impor-
tance of ERPs on patient outcomes and improve implemen-
tation of these programmes while considering the available
skillsets.
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